Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ritsner, Michael S.
Yorkov, Vladimir
Ratner, Yael
Soifer, Peter
and
Gibel, Anatoly
2007.
The effectiveness of ziprasidone in treating impaired quality of life in schizophrenia: A 12-month, open-label, flexible-dose, naturalistic observational study of patients undergoing usual care.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 7,
p.
1470.
Rossi, Alessandro
Vita, Antonio
Tiradritti, Paola
and
Romeo, Fabio
2008.
Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.
International Clinical Psychopharmacology,
Vol. 23,
Issue. 4,
p.
216.
2008.
Current awareness: Pharmacoepidemiology and drug safety.
Pharmacoepidemiology and Drug Safety,
Vol. 17,
Issue. 1,
Eker, SS
Sarandol, A.
Akkaya, C.
Sivrioglu, EY
and
Kirli, S.
2009.
The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
Journal of Psychopharmacology,
Vol. 23,
Issue. 8,
p.
993.
Carvajal, Alfonso
Martín Arias, Luis H.
and
Jimeno, Natalia
2010.
Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactions.
Vol. 32,
Issue. ,
p.
83.
Masdrakis, Vasilios G.
Florakis, Andreas
Tzanoulinos, Georgios
Markatou, Maria
and
Oulis, Panagiotis
2010.
Safety of the Electroconvulsive Therapy-Ziprasidone Combination.
The Journal of ECT,
Vol. 26,
Issue. 2,
p.
139.
Müller, Matthias J.
2011.
Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia.
Schizophrenia Research and Treatment,
Vol. 2011,
Issue. ,
p.
1.
Vothknecht, Sylke
Schoevers, Robert A.
and
de Haan, Lieuwe
2011.
Subjective Well-Being in Schizophrenia as Measured with the Subjective Well-Being Under Neuroleptic Treatment Scale: A Review.
Australian & New Zealand Journal of Psychiatry,
Vol. 45,
Issue. 3,
p.
182.
Park, Subin
Kim, Min-Seon
Namkoong, Churl
Park, Min-Hyeon
and
Hong, Jin Pyo
2012.
The effect of ziprasidone on body weight and energy expenditure in female rats.
Metabolism,
Vol. 61,
Issue. 6,
p.
787.
Lindenmayer, J.
Tedeschi, Frank
Yusim, Anna
Khan, Anzalee
Kaushik, Saurabh
Smith, Robert
and
Parakadavil, Mohan
2012.
Ziprasidone's Effect on Metabolic Markers in Patients with Diabetes and Chronic Schizophrenia.
Clinical Schizophrenia & Related Psychoses,
Vol. 5,
Issue. 4,
p.
185.
Mojtabai, Ramin
Corey-Lisle, Patricia K.
Ip, Edward Hak-Sing
Kopeykina, Irina
Haeri, Sophia
Cohen, Lisa Janet
and
Shumaker, Sally
2012.
The Patient Assessment Questionnaire: Initial validation of a measure of treatment effectiveness for patients with schizophrenia and schizoaffective disorder.
Psychiatry Research,
Vol. 200,
Issue. 2-3,
p.
857.
Park, Subin
Yi, Ki Kyoung
Kim, Min-Seon
and
Hong, Jin Pyo
2013.
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
Behavioral and Brain Functions,
Vol. 9,
Issue. 1,
Awad, A. George
and
Voruganti, Lakshmi N. P.
2013.
The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia.
CNS Drugs,
Vol. 27,
Issue. 8,
p.
625.
Hasnain, Mehrul
and
Vieweg, W. Victor R.
2014.
QTc Interval Prolongation and Torsade de Pointes Associated with Second-Generation Antipsychotics and Antidepressants: A Comprehensive Review.
CNS Drugs,
Vol. 28,
Issue. 10,
p.
887.
Atti, A.R.
Ferrari Gozzi, B.
Zuliani, G.
Bernabei, V.
Scudellari, P.
Berardi, D.
De Ronchi, D.
Tarricone, I.
and
Menchetti, M.
2014.
A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.
International Psychogeriatrics,
Vol. 26,
Issue. 1,
p.
19.
Mandrioli, Roberto
Protti, Michele
and
Mercolini, Laura
2015.
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 11,
Issue. 1,
p.
149.
2016.
Meyler's Side Effects of Drugs.
p.
577.
Fortney, John C.
Bauer, Amy M.
Cerimele, Joseph M.
Pyne, Jeffrey M.
Pfeiffer, Paul
Heagerty, Patrick J.
Hawrilenko, Matt
Zielinski, Melissa J.
Kaysen, Debra
Bowen, Deborah J.
Moore, Danna L.
Ferro, Lori
Metzger, Karla
Shushan, Stephanie
Hafer, Erin
Nolan, John Paul
Dalack, Gregory W.
and
Unützer, Jürgen
2021.
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care.
JAMA Psychiatry,
Vol. 78,
Issue. 11,
p.
1189.
Newcomer, John
Lipsey, Jared
Strassnig, Martin
and
Citrome, Leslie
2024.
The American Psychiatric Association Publishing Textbook of Psychopharmacology.
Comments
No Comments have been published for this article.